Arrowhead Pharmaceuticals Inc (ARWR)
Debt-to-assets ratio
| Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 765,552 | 691,939 | 710,148 | 522,504 | 349,845 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
September 30, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $765,552K
= 0.00
Based on the provided data, Arrowhead Pharmaceuticals Inc. has consistently maintained a debt-to-assets ratio of 0.00 over the past five years. This indicates that the company has not used debt financing to acquire its assets during this period. A debt-to-assets ratio of 0.00 suggests that all of the company's assets have been financed through equity rather than debt. This could be indicative of strong financial health and a conservative approach to leveraging. However, it's important to note that a very low debt-to-assets ratio could also mean that the company is missing out on potential tax advantages associated with debt financing. Overall, the consistent 0.00 debt-to-assets ratio suggests that Arrowhead Pharmaceuticals Inc. has chosen to rely solely on equity to fund its asset base.
Peer comparison
Sep 30, 2023